Back to CLDX
ADAR1 Capital Management, LLC → CLDX
ADAR1 Capital Management, LLC CLDX Position History
Celldex Therapeutics, Inc.
Quarters held
5
Latest value
$25.9M
Q3 2026
Peak value
$25.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $17.6M |
| Q4 2025 | $17.6M |
| Q1 2026 | $13.6M |
| Q2 2026 | $23.1M |
| Q3 2026 | $25.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $25.9M | 799.3K | — | — |
| Q2 2026 | $23.1M | 619.5K | — | — |
| Q1 2026 | $13.6M | 427.8K | — | — |
| Q4 2025 | $17.6M | 646.8K | — | — |
| Q4 2025 | $17.6M | 646.8K | — | — |
Other funds holding CLDX
$343.1M
$250M
$240.9M
$223.4M
$212.9M